Original Publication Date: 16 December, 2013
Publication / Source: Women's Health
Authors: Benjamin Brenner & Irit Avivi
The diagnosis of malignancy during pregnancy is an extremely distressing event for the patient, her family and caregivers. The need to treat the patient for a potentially lethal disease, while minimizing potential risks to the developing fetus, raises significant therapeutic and ethical dilemmas.
Lymphoma presents the fourth most common malignancy in pregnancy, with an estimated prevalence of one in 6000 pregnancies [1–3], whereas leukemia, which is a relatively rare disease, is estimated to occur in one in 75,000–100,000 pregnancies [1,3].